Trials24, a global patient recruitment company, is announcing its participation in the upcoming BIO International Convention in the United States from 3-6 June 2024.
Trials24 will engage with fellow exhibitors and attendees, sharing insights and exploring collaborations to speed up clinical trials by fast-tracking patient recruitment. The company is particularly looking forward to discussions on several key topics, including:
- Projecting patient recruitment costs: With Trials24’s Patient-Reported Feasibility Studies, we build a recruitment cost model that projects patient enrolment costs by measuring the patient population’s eligibility rate specifically to the study protocol.
- Supporting Global Patient Recruitment: Showing with our case studies from common chronic illnesses to rare diseases how we accelerate patient recruitment by tapping into a patient pool study sites can’t reach.
Dr. Tobias Kruse, CEO of Trials24, says: “Connecting with leaders and innovators in biotechnology and clinical research to understand their patient recruitment challenges is the highlight of the BIO International Convention. We look forward to sharing with sponsors and CROs how we can help them accelerate patient recruitment with our approach. Our goal is to seamlessly facilitate the connection between patients and clinical trials, minimising the workload for sites through rigorous pre-qualification of candidates and emphasising enhancing diversity within trials. I personally value the opportunity to engage with industry key leaders to share and learn how to improve clinical trials patient recruitment together.”
Trials24 invites all attendees to join them at booth #4315 in the German Pavilion and to book a meeting via Partnering Platform or by email at info@trials24.com.
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the entire ecosystem of biotech with more than 20,000 industry leaders from across the globe. This event is held by the Biotechnology Innovation Organization (BIO), the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organisations across the US and in 30+ countries.